232 related articles for article (PubMed ID: 10362496)
1. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
Warraich RS; Dunn MJ; Yacoub MH
Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
Lauer B; Padberg K; Schultheiss HP; Strauer BE
Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
4. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
6. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
[TBL] [Abstract][Full Text] [Related]
7. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy.
Warraich RS; Sliwa K; Damasceno A; Carraway R; Sundrom B; Arif G; Essop R; Ansari A; Fett J; Yacoub M
Am Heart J; 2005 Aug; 150(2):263-9. PubMed ID: 16086928
[TBL] [Abstract][Full Text] [Related]
8. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy.
Warraich RS; Pomerance A; Stanley A; Banner NR; Dunn MJ; Yacoub MH
Transplantation; 2000 Apr; 69(8):1609-17. PubMed ID: 10836370
[TBL] [Abstract][Full Text] [Related]
9. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
[TBL] [Abstract][Full Text] [Related]
10. Human cardiac myosin autoantibodies impair myocyte contractility: a cause-and-effect relationship.
Warraich RS; Griffiths E; Falconar A; Pabbathi V; Bell C; Angelini G; Suleiman MS; Yacoub MH
FASEB J; 2006 Apr; 20(6):651-60. PubMed ID: 16581973
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody.
Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M
Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
13. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.
Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ
Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
[TBL] [Abstract][Full Text] [Related]
16. Lack of T cell response to cardiac myosin and a reduced response to PPD in patients with idiopathic dilated cardiomyopathy.
Bromelow KV; Souberbielle B; Alavi A; Goldman JH; Libera LD; Dalgleish AG; McKenna WJ
J Autoimmun; 1997 Apr; 10(2):219-27. PubMed ID: 9185883
[TBL] [Abstract][Full Text] [Related]
17. Anti-heart autoantibodies in familial dilated cardiomyopathy.
Caforio AL; Vinci A; Iliceto S
Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M
Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
[TBL] [Abstract][Full Text] [Related]
20. Genetically determined myocarditis: clinical presentation and immunological characteristics.
Caforio AL; Iliceto S
Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
